Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 3
1994 1
1995 4
1996 4
1997 4
1998 5
1999 9
2000 7
2001 10
2002 10
2003 4
2004 4
2005 8
2006 7
2007 10
2008 14
2009 10
2010 13
2011 19
2012 23
2013 31
2014 28
2015 22
2016 22
2017 13
2018 15
2019 21
2020 26
2021 27
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

350 results
Results by year
Filters applied: . Clear all
Page 1
Leishmaniasis: clinical syndromes and treatment.
McGwire BS, Satoskar AR. McGwire BS, et al. Among authors: satoskar ar. QJM. 2014 Jan;107(1):7-14. doi: 10.1093/qjmed/hct116. Epub 2013 Jun 5. QJM. 2014. PMID: 23744570 Free PMC article. Review.
Revival of Leishmanization and Leishmanin.
Pacheco-Fernandez T, Volpedo G, Gannavaram S, Bhattacharya P, Dey R, Satoskar A, Matlashewski G, Nakhasi HL. Pacheco-Fernandez T, et al. Among authors: satoskar a. Front Cell Infect Microbiol. 2021 Mar 17;11:639801. doi: 10.3389/fcimb.2021.639801. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816344 Free PMC article. Review.
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Dubovsky JA, Beckwith KA, Natarajan G, Woyach JA, Jaglowski S, Zhong Y, Hessler JD, Liu TM, Chang BY, Larkin KM, Stefanovski MR, Chappell DL, Frissora FW, Smith LL, Smucker KA, Flynn JM, Jones JA, Andritsos LA, Maddocks K, Lehman AM, Furman R, Sharman J, Mishra A, Caligiuri MA, Satoskar AR, Buggy JJ, Muthusamy N, Johnson AJ, Byrd JC. Dubovsky JA, et al. Among authors: satoskar ar. Blood. 2013 Oct 10;122(15):2539-49. doi: 10.1182/blood-2013-06-507947. Epub 2013 Jul 25. Blood. 2013. PMID: 23886836 Free PMC article. Clinical Trial.
Host-directed therapies for parasitic diseases.
Singh B, Varikuti S, Halsey G, Volpedo G, Hamza OM, Satoskar AR. Singh B, et al. Among authors: satoskar ar. Future Med Chem. 2019 Aug;11(15):1999-2018. doi: 10.4155/fmc-2018-0439. Epub 2019 Aug 8. Future Med Chem. 2019. PMID: 31390889 Review.
Establishing a Case for Anti-complement Therapy in Membranous Nephropathy.
Ayoub I, Shapiro JP, Song H, Zhang XL, Parikh S, Almaani S, Madhavan S, Brodsky SV, Satoskar A, Bott C, Yu L, Merchant M, Klein J, Mejia-Vilet JM, Nadasdy T, Birmingham D, Rovin BH. Ayoub I, et al. Among authors: satoskar a. Kidney Int Rep. 2020 Dec 13;6(2):484-492. doi: 10.1016/j.ekir.2020.11.032. eCollection 2021 Feb. Kidney Int Rep. 2020. PMID: 33615073 Free PMC article.
Membranous Nephropathy With Crescents.
Alawieh R, Brodsky SV, Satoskar AA, Nadasdy T, Parikh SV, Rovin B, Cassol CA. Alawieh R, et al. Among authors: satoskar aa. Kidney Int Rep. 2020 Jan 30;5(4):537-541. doi: 10.1016/j.ekir.2020.01.010. eCollection 2020 Apr. Kidney Int Rep. 2020. PMID: 32274459 Free PMC article. No abstract available.
MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.
Jha BK, Varikuti S, Seidler GR, Volpedo G, Satoskar AR, McGwire BS. Jha BK, et al. Among authors: satoskar ar. Infect Immun. 2020 Jun 22;88(7):e00948-19. doi: 10.1128/IAI.00948-19. Print 2020 Jun 22. Infect Immun. 2020. PMID: 32312766 Free PMC article.
Can Antinuclear Antibodies (ANA) be Monoclonal?
Biederman L, Satoskar AA, Doraiswamy M, Parikh S, Rovin B, Mussio B, Mikhalina G, Brodsky SV. Biederman L, et al. Among authors: satoskar aa. Case Rep Nephrol. 2021 Sep 30;2021:7006466. doi: 10.1155/2021/7006466. eCollection 2021. Case Rep Nephrol. 2021. PMID: 34631181 Free PMC article.
350 results